Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Ra Pharmaceuticals reports initial data from study of RA-101495 in PNH

June 28, 2017

Danazol shows promise for treating MDS-associated thrombocytopenia

June 27, 2017

FDA approves Bevyxxa for hospital and extended-duration prophylaxis of VTE

June 26, 2017

FDA approves subcutaneous Haegarda to prevent HAE attacks

June 23, 2017

Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors

June 23, 2017

ISU Abxis is enrolling patients in phase I trial of ISU-304

June 23, 2017

EMA validates Veyvondi MAA

June 22, 2017

FDA accepts Rigel Pharmaceuticals' NDA for fostamatinib disodium

June 20, 2017

Leids Universitair Medisch Centrum presents recombinant serine protease variants

June 15, 2017

FDA accepts Bioverativ's IND for BIVV-001 for hemophilia A

June 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...